Literature DB >> 7629045

Differential response of the NADH oxidase of plasma membranes of rat liver and hepatoma and HeLa cells to thiol reagents.

D J Morré1, D M Morré.   

Abstract

NADH oxidase activity of plasma membranes from rat hepatoma and HeLa cells responded to thiol reagents in a manner different from that of plasma membranes of liver. Specifically, the NADH oxidase activity of plasma membranes of HeLa cells was inhibited by submicromolar concentrations of the thiol reagents p-chloromercuribenzoate (PCMB), N-ethylmaleimide (NEM), or 5,5'-dithiobis-(2-nitrophenylbenzoic acid) (DTNB), whereas that of the rat liver plasma membranes was unaffected or stimulated over a wide range of concentrations extending into the millimolar range. With some hepatoma preparations, the NADH oxidase activity of hepatoma plasma membranes was stimulated rather than inhibited by PCMB, whereas with all preparations of hepatoma plasma membranes, NEM and DTNB stimulated the activity. In contrast, NADH oxidase activity of rat liver plasma membrane was largely unaffected over the same range of PCMB concentrations that either stimulated or inhibited with rat hepatoma or HeLa cell plasma membranes. Dithiothreitol and glutathione stimulated NADH oxidase activity of plasma membranes of rat liver and hepatoma but inhibited that of HeLa plasma membranes. The findings demonstrate a difference between the NADH oxidase activity of normal rat liver plasma membranes of rat hepatoma and HeLa cell plasma membranes in addition to the differential response to growth factors and hormones reported previously (Bruno et al., 1992). Results are consistent with a structural modification of a NADH oxidase activity involving thiol groups present in plasma membranes of rat hepatoma and HeLa cells but absent or inaccessible with plasma membranes of rat liver.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7629045     DOI: 10.1007/bf02110341

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  21 in total

1.  Preparation of mammalian plasma membranes by aqueous two-phase partition.

Authors:  D J Morré; D M Morré
Journal:  Biotechniques       Date:  1989-10       Impact factor: 1.993

2.  Molecular cloning and complete amino-acid sequence of form-I phosphoinositide-specific phospholipase C.

Authors:  C F Bennett; J M Balcarek; A Varrichio; S T Crooke
Journal:  Nature       Date:  1988-07-21       Impact factor: 49.962

Review 3.  Thioredoxin.

Authors:  A Holmgren
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

Review 4.  Transplasma-membrane redox systems in growth and development.

Authors:  F L Crane; I L Sun; M G Clark; C Grebing; H Löw
Journal:  Biochim Biophys Acta       Date:  1985-08-01

5.  NADH oxidase activity of rat liver plasma membrane activated by guanine nucleotides.

Authors:  D J Morré; M Davidson; C Geilen; J Lawrence; G Flesher; R Crowe; F L Crane
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

6.  Two different modifications of the neuroblastoma X glioma hybrid opiate receptors induced by N-ethylmaleimide.

Authors:  N E Larsen; D Mullikin-Kilpatrick; A J Blume
Journal:  Mol Pharmacol       Date:  1981-09       Impact factor: 4.436

7.  Evidence for essential thiol groups and disulfide bonds in agonist and antagonist binding to the dopamine receptor.

Authors:  E T Suen; E Stefanini; Y C Clement-Cormier
Journal:  Biochem Biophys Res Commun       Date:  1980-09-30       Impact factor: 3.575

8.  Differential inactivation of vasopressin receptor subtypes in isolated membranes and intact cells by N-ethylmaleimide.

Authors:  I Pávó; F Fahrenholz
Journal:  FEBS Lett       Date:  1990-10-15       Impact factor: 4.124

9.  Modulation of ligand binding to leukotriene B4 receptors on guinea pig lung membranes by sulfhydryl modifying reagents.

Authors:  R C Falcone; D Aharony
Journal:  J Pharmacol Exp Ther       Date:  1990-11       Impact factor: 4.030

10.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

View more
  6 in total

1.  Structural changes revealed by Fourier transform infrared and circular dichroism spectroscopic analyses underlie tNOX periodic oscillations.

Authors:  Chinpal Kim; Sara Layman; Dorothy M Morré; D James Morré
Journal:  Dose Response       Date:  2006-05-01       Impact factor: 2.658

2.  Decomposition Analyses Applied to a Complex Ultradian Biorhythm: The Oscillating NADH Oxidase Activity of Plasma Membranes Having a Potential Time-Keeping (Clock) Function.

Authors:  Ken Foster; Nasim Anwar; Rhea Pogue; Dorothy M Morré; T W Keenan; D James Morré
Journal:  Nonlinearity Biol Toxicol Med       Date:  2003-01

3.  The sulfonylurea-inhibited NADH oxidase activity of HeLa cell plasma membranes has properties of a protein disulfide-thiol oxidoreductase with protein disulfide-thiol interchange activity.

Authors:  D J Morré; P J Chueh; J Lawler; D M Morré
Journal:  J Bioenerg Biomembr       Date:  1998-10       Impact factor: 2.945

4.  A circulating form of NADH oxidase activity responsive to the antitumor sulfonylurea N-4-(methylphenylsulfonyl)-N'-(4-chlorophenyl)urea (LY181984) specific to sera from cancer patients.

Authors:  D J Morré; T Reust
Journal:  J Bioenerg Biomembr       Date:  1997-06       Impact factor: 2.945

5.  Is the drug-responsive NADH oxidase of the cancer cell plasma membrane a molecular target for adriamycin?

Authors:  D J Morré; C Kim; M Paulik; D M Morré; W P Faulk
Journal:  J Bioenerg Biomembr       Date:  1997-06       Impact factor: 2.945

6.  Use of dipyridyl-dithio substrates to measure directly the protein disulfide-thiol interchange activity of the auxin stimulated NADH: protein disulfide reductase (NADH oxidase) of soybean plasma membranes.

Authors:  D J Morré; M L Gomez-Rey; C Schramke; O Em; J Lawler; J Hobeck; D M Morré
Journal:  Mol Cell Biochem       Date:  1999-10       Impact factor: 3.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.